Rationale and design of MILES-3 and MILES-4 studies: two randomized phase 3 trials comparing single-agent chemotherapy versus cisplatin-based doublets in elderly patients with advanced non--small-cell lung cancer.
第一作者:
Cesare,Gridelli
第一单位:
Medical Oncology, S.G. Moscati Hospital, Avellino, Italy.
作者:
主题词
腺癌(Adenocarcinoma);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);顺铂(Cisplatin);脱氧胞苷(Deoxycytidine);女(雌)性(Female);随访研究(Follow-Up Studies);谷氨酸盐类(Glutamates);鸟嘌呤(Guanine);人类(Humans);肺肿瘤(Lung Neoplasms);淋巴转移(Lymphatic Metastasis);男(雄)性(Male);肿瘤分期(Neoplasm Staging);预后(Prognosis);前瞻性研究(Prospective Studies);生活质量(Quality of Life);研究设计(Research Design);存活率(Survival Rate)
DOI
10.1016/j.cllc.2013.11.011
PMID
24418693
发布时间
2022-12-07
- 浏览79

Clinical lung cancer
166-70页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文